Astellas & Merck & Co: Alliance Management, Managing the Business of the Alliance




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Astellas & Merck & Co: Alliance Management, Managing the Business of the Alliance
Released on: August 01, 2012. © PharmaTelevision Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Mary Jo Struttmann, Senior Director Alliance Management at Astellas US and Brian Daly, Head of Alliance Management for Merck's Worldwide Licensing and Business Development organizations.
  • Summary
  • Transcript
  • Participants
  • Company
In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Mary Jo Struttmann, Senior Director Alliance Management at Astellas US and Brian Daly, Head of Alliance Management for Merck's Worldwide Licensing and Business Development organizations.
In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Mary Jo Struttmann, Senior Director Alliance Management at Astellas US and Brian Daly, Head of Alliance Management for Merck's Worldwide Licensing and Business Development organizations. They discuss the Alliance Management function within their own organisations, the attributes required within the role and also talk about their involvement with ASAP, The Association of Strategic Alliance Professionals.
Mary Jo Struttmann, Brian Daly
Astellas and Merck & Co
Astellas Pharma
Astellas Pharma Inc., to fulfill its business philosophy to "Contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products," is actively engaged in business as an R&D-driven global pharmaceutical company.
Merck & Co.
Merck & Co., Inc., also known as Merck Sharp & Dohme or MSD outside the United States and Canada, is one of the largest pharmaceutical companies in the world. The headquarters of the company is located in Whitehouse Station, New Jersey, an unincorporated area in Readington Township. It was established in 1891 as the United States subsidiary of the German company now known as Merck KGaA. In common with many other German assets in the United States, Merck & Co. was confiscated in 1917 during World War I and set up as an independent company. It is currently one of the seven largest pharmaceutical companies in the world both by market capitalisation and revenue.

Merck's products cover a broad range of areas, including heart and respiratory health, infectious diseases, sun care and women’s health. And Merck focuses its research on conditions that affect millions of people around the world – diseases like Alzheimer’s, diabetes and cancer – while building strengths in new areas like biologics.